Header Image
4. Copy number variations as gene candidates in ADHD

4. Copy number variations as gene candidates in ADHD

Copy number variants (CNVs) are genetic variations that include deletions and duplications of chromosome segments. CNVs occur in less than 1% of the total population. However, they have a major impact on the risk of1

  • ADHD234
  • ASS
  • mental disability
  • Schizophrenia
  • physical illnesses

4. Copy number variations (CNV) that could be involved in ADHD

Gene databases:
omim.org and http://www.uniprot.org/

4.1. 22Q11.2 Duplication / deletion

The 22q11.2-deletion syndrome Occurs once in 2150 births, the prevalence of ADHD at 22q11.2Del is around 6% to 37%.5

The 22q11.2-duplication syndrome Occurs once in 1600 births, the ADHD prevalence at 22q11.2Dup is around 18.2 % to 44 %.5

More on this under Monogenetic causes of ADHD.

4.2. 2P16.3 (NRXN1)

Exonic NRXN1 deletions occur in 0.039 to 0.07% of all people and are associated with a 10 to 20% risk of ADHD and an up to 20-fold increased risk of other psychiatric disorders.
More on this under Monogenetic causes of ADHD.

4.3. 15Q11.2 (BP4)

Deletion.2

4.4. 15Q13.3 (BP4.5-BP5)

Deletion.2

4.5. 22Q11.21 (COMT)

Deletion.2

Duplication.2

4.6. 1Q21.1 distal

Duplication.2

1q21.1 (BP 3-4) loss/gain
Duplication.
HR: 2.656

4.7. 16P11.2

proximal

Duplication.2

16p11.2 deletion is one of the most common copy number variations associated with neuronal developmental disorders such as ADHD, ASD and intellectual disability7

4.8. 16P13.11

Duplication.2
16p13.11 (BP 2-3) HR: 2.016

16p13.11 (BP 2-3)
Deletion.
HR: 2.266

4.9. 16P13.2

Source:8

4.10. 17Q12 (HNF1B) loss/gain

Deletion.
HR: 4.2469

Duplication.
HR: 4.196

4.11. 16P12.1 (EEF2K, CDR2)

Deletion.
HR: 1.866

4.12. 15Q13.3 (BP 4-5)

Deletion.
HR: 2.516

4.13. 15Q11.2 (BP 1-2)

Deletion.
HR: 1.436

Duplication.
HR: 1.426

4.14. 2Q11.2 (A-B) loss/gain

Duplication.
HR: 2.616

4.15. 16P11.2 (BP 4-5) loss/gain

Duplication.
HR: 2.636

4.16. TAR (BP 2-3) loss

Duplication.
HR: 1.766

4.17. PWAS (BP 2-3) loss/gain

Duplication.
HR: 3.646

4.18. 16P11.2 (BP 4-5) loss/gain

Duplication.
HR: 2.636

4.19 Int22h1/int22h2-mediated Xq28 duplication syndrome (32 %)

Among males with int22h1/int22h2-mediated Xq28 duplication syndrome, ADHD was found in 32%.10


  1. Dennison CA, Martin J, Shakeshaft A, Riglin L, Powell V, Kirov G, Owen MJ, O’Donovan MC, Thapar A (2025): Early manifestations of neurodevelopmental copy number variants in children: A population-based investigation. Biol Psychiatry. 2025 Mar 14:S0006-3223(25)01050-9. doi: 10.1016/j.biopsych.2025.03.004. PMID: 40090564.

  2. Gudmundsson, Walters, Ingason, Johansson, Zayats, Athanasiu, Sonderby, Gustafsson, Nawaz, Jonsson, Jonsson, Knappskog, Ingvarsdottir, Davidsdottir, Djurovic, Knudsen, Askeland, Haraldsdottir, Baldursson, Magnusson, Sigurdsson, Gudbjartsson, Stefansson, Andreassen, Haavik, Reichborn-Kjennerud, Stefansson (2019): Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder. Transl Psychiatry. 2019 Oct 17;9(1):258. doi: 10.1038/s41398-019-0599-y.

  3. Ramos-Quiroga JA, Sánchez-Mora C, Casas M, Garcia-Martínez I, Bosch R, Nogueira M, Corrales M, Palomar G, Vidal R, Coll-Tané M, Bayés M, Cormand B, Ribasés M (2014): Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. J Psychiatr Res. 2014 Feb;49:60-7. doi: 10.1016/j.jpsychires.2013.10.022. PMID: 24269040.

  4. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, Stefansson H, Stefansson K, Magnusson P, Gudmundsson OO, Gustafsson O, Holmans P, Owen MJ, O’Donovan M, Thapar A (2010): Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet. 2010 Oct 23;376(9750):1401-8. doi: 10.1016/S0140-6736(10)61109-9. PMID: 20888040; PMCID: PMC2965350.

  5. Sauter C, Romanos M, Radtke, F (2024): Deletions- und Duplikationssyndrom 22q11.2 und ADHS, neue AKZENTE Nr. 129 3/2024, 10

  6. Vaez M, Montalbano S, Calle Sánchez X, Georgii Hellberg KL, Dehkordi SR, Krebs MD, Meijsen J, Shorter J, Bybjerg-Grauholm J, Mortensen PB, Børglum AD, Hougaard DM, Nordentoft M, Geschwind DH, Buil A, Schork AJ, Helenius D, Raznahan A, Thompson WK, Werge T, Ingason A; iPSYCH Investigators (2024): Population-Based Risk of Psychiatric Disorders Associated With Recurrent Copy Number Variants. JAMA Psychiatry. 2024 Oct 1;81(10):957-966. doi: 10.1001/jamapsychiatry.2024.1453. PMID: 38922630; PMCID: PMC11209205.

  7. Kelvington BA, Kim J, Fair R, Gaine ME, Abel T (2025): Complement contributes to hyperactive behavior in the 16p11.2 hemideletion mouse model. bioRxiv [Preprint]. 2025 Aug 21:2025.08.21.671537. doi: 10.1101/2025.08.21.671537. PMID: 40894701; PMCID: PMC12393526.

  8. Gregersen NO, Lydersen LN, Biskopstø M, Zachariasen JF, Jespersen RF, Stórá T, Andorsdóttir G, Wang AG (2024): Whole-exome sequencing implicates 16p13.2 as a risk locus for attention-deficit/hyperactivity disorder in the Faroese population. Psychiatr Genet. 2024 Aug 1;34(4):91. doi: 10.1097/YPG.0000000000000370. PMID: 38958187.

  9. Mitchel MW, Moreno-De-Luca D, Myers SM, Levy RV, Turner S, Ledbetter DH, Martin CL (2016): 17q12 Recurrent Deletion Syndrome. 2016 Dec 8 [updated 2025 Aug 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 27929632. REVIEW

  10. Ballout RA, El-Hattab AW, Schaaf CP, Cheung SW (2016): Xq28 Duplication Syndrome, Int22h1/Int22h2 Mediated. 2016 Mar 10 [updated 2025 Sep 4]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 26962617. REVIEW

Diese Seite wurde am 01.03.2026 zuletzt aktualisiert.